{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:29:45Z","timestamp":1740133785751,"version":"3.37.3"},"reference-count":30,"publisher":"BMJ","issue":"10","funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81670851"],"award-info":[{"award-number":["No. 81670851"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>To characterise the genotype(s), phenotype(s) and age-related penetrance of glaucoma in a Chinese family with primary open-angle glaucoma (POAG).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Recruited from a Chinese family spanning four generations, 7 individuals with POAG, 1 with ocular hypertension (OHT) and 14 unaffected individuals were included in this study. Genotypic investigation included sequencing of mutation sites using a glaucoma panel in combination with high-throughput sequencing and validated using Sanger sequencing. Phenotypic characterisation included investigation into patient medical history and physical examination.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eight (36.4%) family members harboured heterozygous Y437H mutation, of whom seven (87.5%) were glaucomatous and one (12.5%) had OHT. The mean age of POAG diagnosis was 30.85\u00b17.13 years. The mean highest recorded intraocular pressure (IOP) was 46.57\u00b16.53 mm Hg. They all had complained of symptoms associated with vision and pain. Four (57.1%) patients presented blindness. Five eyes (62.5%) presented with severe and three eyes with moderate visual field defects. Most of them underwent surgery on average 1.29\u00b12.36 years after diagnosis, and the mean IOP at study was 17.95\u00b17.23 mm Hg, with an average of 0.92\u00b10.86 eye-drops. The patient with OHT was treated with latanoprost only and her IOP was well controlled. Age-related glaucoma penetrance was 0% in individuals under the age of 20 years, 50% at ages 20\u201335 years, 75% at ages 31\u201335 years and 87.5% over 45 years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>A novel <jats:italic>MYOC<\/jats:italic> mutation (c.1309T&gt;C, p.Y437H) in a Chinese family with POAG was identified which was associated with a phenotype characterised by severe visual impairment, frequent surgical intervention requirement and relatively high penetrance.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjophthalmol-2018-313069","type":"journal-article","created":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T22:15:16Z","timestamp":1546726516000},"page":"1524-1529","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["The clinical feature of myocilin Y437H mutation in a Chinese family with primary open-angle glaucoma"],"prefix":"10.1136","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4705-0676","authenticated-orcid":false,"given":"Lei","family":"Lei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shushan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,1,5]]},"reference":[{"key":"2020050713022489000_103.10.1524.1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.081224"},{"key":"2020050713022489000_103.10.1524.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804630"},{"key":"2020050713022489000_103.10.1524.3","doi-asserted-by":"crossref","first-page":"OT07","DOI":"10.21276\/aimdr.2018.4.2.OT3","article-title":"Clinical profile of primary open angle glaucoma suspects","volume":"4","author":"Mohan","year":"2018","journal-title":"Ann Int Med Den Res"},{"key":"2020050713022489000_103.10.1524.4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-3-540-69475-5_2","article-title":"The epidemiology of glaucoma28 spec","volume":"2","author":"Giangiacomo","year":"2009","journal-title":"Essent. Ophthalmol"},{"key":"2020050713022489000_103.10.1524.5","doi-asserted-by":"publisher","DOI":"10.1097\/00055735-200004000-00006"},{"key":"2020050713022489000_103.10.1524.6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.exer.2017.05.002","article-title":"Major review: Molecular genetics of primary open-angle glaucoma","volume":"160","author":"Liu","year":"2017","journal-title":"Exp Eye Res"},{"key":"2020050713022489000_103.10.1524.7","doi-asserted-by":"publisher","DOI":"10.1126\/science.1066901"},{"key":"2020050713022489000_103.10.1524.8","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddi068"},{"key":"2020050713022489000_103.10.1524.9","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr572"},{"key":"2020050713022489000_103.10.1524.10","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr123"},{"key":"2020050713022489000_103.10.1524.11","doi-asserted-by":"publisher","DOI":"10.1086\/302098"},{"key":"2020050713022489000_103.10.1524.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(02)00353-3"},{"key":"2020050713022489000_103.10.1524.13","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddh074"},{"key":"2020050713022489000_103.10.1524.14","doi-asserted-by":"crossref","unstructured":"Rangachari K , Bankoti N , Shyamala N , et al . Glaucoma Pred: Glaucoma prediction based on Myocilin genotype and phenotype information. Genomics 2018.doi:10.1016\/j.ygeno.2018.04.006","DOI":"10.1016\/j.ygeno.2018.04.006"},{"key":"2020050713022489000_103.10.1524.15","first-page":"2324","article-title":"Characterization of myocilin-myocilin interactions","volume":"42","author":"Fautsch","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020050713022489000_103.10.1524.16","first-page":"151","article-title":"In vitro localization of TIGR\/MYOC in trabecular meshwork extracellular matrix and binding to fibronectin.J","volume":"43","author":"Filla","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020050713022489000_103.10.1524.17","first-page":"369","article-title":"A recurrent G367R mutation in MYOC associated with juvenile open angle glaucoma in a large Chinese family","volume":"11","author":"Yao","year":"2018","journal-title":"Int. J. Ophthalmol"},{"key":"2020050713022489000_103.10.1524.18","doi-asserted-by":"crossref","first-page":"xxiv","DOI":"10.1016\/j.ajo.2018.02.016","article-title":"What we have learned from the ocular hypertension treatment study","volume":"189","author":"Gordon","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"2020050713022489000_103.10.1524.19","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5300.668"},{"key":"2020050713022489000_103.10.1524.20","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.8.1172"},{"key":"2020050713022489000_103.10.1524.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(00)00536-5"},{"key":"2020050713022489000_103.10.1524.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)00654-6"},{"key":"2020050713022489000_103.10.1524.23","first-page":"2288","article-title":"Gln368STOP myocilin mutation in families with late-onset primary open-angle glaucoma","volume":"39","author":"Allingham","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020050713022489000_103.10.1524.24","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddh128"},{"key":"2020050713022489000_103.10.1524.25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI58183"},{"key":"2020050713022489000_103.10.1524.26","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/10.2.117"},{"key":"2020050713022489000_103.10.1524.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2003.10.162"},{"key":"2020050713022489000_103.10.1524.28","doi-asserted-by":"publisher","DOI":"10.1016\/S1350-9462(02)00010-1"},{"key":"2020050713022489000_103.10.1524.29","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.090853"},{"key":"2020050713022489000_103.10.1524.30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.exer.2017.01.006","article-title":"Myocilin expression is regulated by retinoic acid in the trabecular meshwork-derived cellular environment","volume":"155","author":"Prat","year":"2017","journal-title":"Exp Eye Res"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2018-313069","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:58:48Z","timestamp":1601110728000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2018-313069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,5]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,9,19]]},"published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1136\/bjophthalmol-2018-313069"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313069","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"type":"print","value":"0007-1161"},{"type":"electronic","value":"1468-2079"}],"subject":[],"published":{"date-parts":[[2019,1,5]]}}}